AZTA
Price
$32.41
Change
+$0.07 (+0.22%)
Updated
Aug 4 closing price
Capitalization
3.36B
Earnings call today
BAX
Price
$22.44
Change
+$0.48 (+2.19%)
Updated
Aug 4 closing price
Capitalization
21.77B
86 days until earnings call
Interact to see
Advertisement

AZTA vs BAX

Header iconAZTA vs BAX Comparison
Open Charts AZTA vs BAXBanner chart's image
Azenta
Price$32.41
Change+$0.07 (+0.22%)
Volume$1.04M
Capitalization3.36B
Baxter International
Price$22.44
Change+$0.48 (+2.19%)
Volume$11.39M
Capitalization21.77B
AZTA vs BAX Comparison Chart in %
Loading...
AZTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AZTA vs. BAX commentary
Aug 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZTA is a Hold and BAX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 05, 2025
Stock price -- (AZTA: $32.41 vs. BAX: $22.44)
Brand notoriety: AZTA and BAX are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: AZTA: 130% vs. BAX: 189%
Market capitalization -- AZTA: $3.36B vs. BAX: $21.77B
AZTA [@Medical Specialties] is valued at $3.36B. BAX’s [@Medical Specialties] market capitalization is $21.77B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.69B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AZTA’s FA Score shows that 0 FA rating(s) are green whileBAX’s FA Score has 0 green FA rating(s).

  • AZTA’s FA Score: 0 green, 5 red.
  • BAX’s FA Score: 0 green, 5 red.
According to our system of comparison, BAX is a better buy in the long-term than AZTA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AZTA’s TA Score shows that 3 TA indicator(s) are bullish while BAX’s TA Score has 4 bullish TA indicator(s).

  • AZTA’s TA Score: 3 bullish, 5 bearish.
  • BAX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, AZTA is a better buy in the short-term than BAX.

Price Growth

AZTA (@Medical Specialties) experienced а -5.04% price change this week, while BAX (@Medical Specialties) price change was -21.32% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.12%. For the same industry, the average monthly price growth was -1.52%, and the average quarterly price growth was -4.55%.

Reported Earning Dates

AZTA is expected to report earnings on Nov 18, 2025.

BAX is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Medical Specialties (-1.12% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BAX($21.8B) has a higher market cap than AZTA($3.36B). BAX YTD gains are higher at: -22.240 vs. AZTA (-35.180). BAX has higher annual earnings (EBITDA): 1.67B vs. AZTA (57.5M). BAX has more cash in the bank: 3.19B vs. AZTA (984M). AZTA has less debt than BAX: AZTA (66.5M) vs BAX (14.4B). BAX has higher revenues than AZTA: BAX (14.8B) vs AZTA (641M).
AZTABAXAZTA / BAX
Capitalization3.36B21.8B15%
EBITDA57.5M1.67B3%
Gain YTD-35.180-22.240158%
P/E RatioN/A85.61-
Revenue641M14.8B4%
Total Cash984M3.19B31%
Total Debt66.5M14.4B0%
FUNDAMENTALS RATINGS
AZTA vs BAX: Fundamental Ratings
AZTA
BAX
OUTLOOK RATING
1..100
664
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
50
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
6365
P/E GROWTH RATING
1..100
6036
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AZTA's Valuation (50) in the Electronic Production Equipment industry is in the same range as BAX (50) in the Medical Specialties industry. This means that AZTA’s stock grew similarly to BAX’s over the last 12 months.

AZTA's Profit vs Risk Rating (100) in the Electronic Production Equipment industry is in the same range as BAX (100) in the Medical Specialties industry. This means that AZTA’s stock grew similarly to BAX’s over the last 12 months.

AZTA's SMR Rating (100) in the Electronic Production Equipment industry is in the same range as BAX (100) in the Medical Specialties industry. This means that AZTA’s stock grew similarly to BAX’s over the last 12 months.

AZTA's Price Growth Rating (63) in the Electronic Production Equipment industry is in the same range as BAX (65) in the Medical Specialties industry. This means that AZTA’s stock grew similarly to BAX’s over the last 12 months.

BAX's P/E Growth Rating (36) in the Medical Specialties industry is in the same range as AZTA (60) in the Electronic Production Equipment industry. This means that BAX’s stock grew similarly to AZTA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AZTABAX
RSI
ODDS (%)
Bearish Trend 1 day ago
75%
Bullish Trend 1 day ago
47%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
80%
Bullish Trend 1 day ago
58%
Momentum
ODDS (%)
Bullish Trend 1 day ago
72%
Bearish Trend 1 day ago
70%
MACD
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 1 day ago
65%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
61%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
63%
Advances
ODDS (%)
Bullish Trend 14 days ago
70%
Bullish Trend 1 day ago
51%
Declines
ODDS (%)
Bearish Trend 5 days ago
84%
Bearish Trend 6 days ago
59%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
76%
Bullish Trend 1 day ago
62%
Aroon
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
54%
View a ticker or compare two or three
Interact to see
Advertisement
AZTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JGACX31.19N/A
N/A
JPMorgan Growth Advantage C
RSMOX24.18N/A
N/A
Victory RS Mid Cap Growth A
TINCX2.68N/A
N/A
Templeton Global Balanced A1
SSMAX9.82N/A
N/A
SEI Small/Mid Cap Equity A (SIIT)
IDVSX26.31N/A
N/A
Morgan Stanley Inst Intl Advtg R6

AZTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, AZTA has been loosely correlated with MTD. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if AZTA jumps, then MTD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AZTA
1D Price
Change %
AZTA100%
+0.22%
MTD - AZTA
65%
Loosely correlated
+2.89%
RVTY - AZTA
64%
Loosely correlated
+0.10%
A - AZTA
64%
Loosely correlated
+1.18%
IQV - AZTA
60%
Loosely correlated
+0.16%
BRKR - AZTA
59%
Loosely correlated
-8.62%
More

BAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BAX has been closely correlated with ALGN. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if BAX jumps, then ALGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BAX
1D Price
Change %
BAX100%
+2.19%
ALGN - BAX
68%
Closely correlated
+0.92%
STE - BAX
51%
Loosely correlated
+0.69%
SYK - BAX
51%
Loosely correlated
+0.98%
AZTA - BAX
48%
Loosely correlated
+0.22%
NVST - BAX
47%
Loosely correlated
-1.68%
More